148 related articles for article (PubMed ID: 3783204)
1. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.
Wils J; Bleiberg H; Dalesio O; Blijham G; Mulder N; Planting A; Splinter T; Duez N
J Clin Oncol; 1986 Dec; 4(12):1799-803. PubMed ID: 3783204
[TBL] [Abstract][Full Text] [Related]
2. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
Wils JA; Klein HO; Wagener DJ; Bleiberg H; Reis H; Korsten F; Conroy T; Fickers M; Leyvraz S; Buyse M
J Clin Oncol; 1991 May; 9(5):827-31. PubMed ID: 2016625
[TBL] [Abstract][Full Text] [Related]
3. An EORTC gastrointestinal (GI) group randomized evaluation of the toxicity of sequential high dose methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) vs 5-fluorouracil, adriamycin and mitomycin (FAM) in advanced gastric cancer.
Klein HO; Wils J; Bleiberg H; Buyse M; Duez N
Med Oncol Tumor Pharmacother; 1989; 6(2):171-4. PubMed ID: 2664372
[TBL] [Abstract][Full Text] [Related]
4. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR
J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836
[TBL] [Abstract][Full Text] [Related]
5. Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer.
Klein HO
Anticancer Res; 1989; 9(4):1025-6. PubMed ID: 2817784
[TBL] [Abstract][Full Text] [Related]
6. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
[TBL] [Abstract][Full Text] [Related]
7. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
[TBL] [Abstract][Full Text] [Related]
8. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma.
Ajani JA; Goudeau P; Levin B; Faintuch JS; Abbruzzese JL; Boman BM; Kanojia MD
Cancer Chemother Pharmacol; 1989; 24(1):41-4. PubMed ID: 2720890
[TBL] [Abstract][Full Text] [Related]
10. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.
Levi JA; Fox RM; Tattersall MH; Woods RL; Thomson D; Gill G
J Clin Oncol; 1986 Sep; 4(9):1348-55. PubMed ID: 3528404
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
Coombes RC; Schein PS; Chilvers CE; Wils J; Beretta G; Bliss JM; Rutten A; Amadori D; Cortes-Funes H; Villar-Grimalt A
J Clin Oncol; 1990 Aug; 8(8):1362-9. PubMed ID: 2199622
[TBL] [Abstract][Full Text] [Related]
13. Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer.
Muro H; Acuña LR; Castagnari A; Blajman C; Schmilovich A; Hidalgo A; Fiori H; Bader M; Marantz A
Cancer Treat Rep; 1986 Nov; 70(11):1333-4. PubMed ID: 3768875
[No Abstract] [Full Text] [Related]
14. A phase II trial of sequential MTx and 5-FU alternated with 4-epidoxorubicin and cisplatin in advanced gastric cancer.
Taal BG; ten Bokkel Huinink WW; Simonetti G; Franklin H; McVie JG
Cancer Invest; 1990; 8(5):501-4. PubMed ID: 2265372
[TBL] [Abstract][Full Text] [Related]
15. [Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer].
Sasaki T; Ota K; Ibayashi J; Sakata Y; Matsuoka T; Ishikawa M; Wakui A; Ogoshi K; Akazawa S; Sakai Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2545-55. PubMed ID: 2673045
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G; Bella M; Zironi S; Algeri R; Di Costanzo F; De Lisi V; Luppi G; Mazzocchi B; Rodinò C; Soldani M
J Clin Oncol; 1994 Dec; 12(12):2687-93. PubMed ID: 7989945
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
[TBL] [Abstract][Full Text] [Related]
18. [A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer].
Yamamura Y; Kodera Y; Kito T
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1407-10. PubMed ID: 7668879
[No Abstract] [Full Text] [Related]
19. High-dose MTX/5-FU and adriamycin for gastric cancer.
Klein HO; Wickramanayake PD; Dieterle F; Mohr R; Oerkermann H; Gross R
Semin Oncol; 1983 Jun; 10(2 Suppl 2):29-31. PubMed ID: 6603023
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
